Has William Roman Torreguitart, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,542 in general payments to William Roman Torreguitart, MD across 55 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Roman Torreguitart, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Roman Torreguitart, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Roman Torreguitart, MD

Urology · Mayaguez, PRNPI 1780600072

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,463 of the $5,542 with a category attached, or 80.5%. It is spread thinly across 18 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations.

$5,542in general payments, 2019–2025

Across 55 payments — averaging $100.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$1K
Procept Biorobotics Corporation$1K
Johnson & Johnson$714
Teleflex LLC$675
Merck$388
Medtronic$247
plus $1K from 12 others

What the payments were for

Travel & lodging$1,07919%
Food & beverage$4,46381%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	15	$1,118
Procept Biorobotics Corporation	1	$1,079
Johnson & Johnson	8	$714
Teleflex LLC	7	$675
Merck	4	$388
Medtronic	4	$247
E.r. Squibb & Sons, L.L.C.	2	$225
Neotract Inc.	2	$217
Axonics, Inc.	1	$121
Travere Therapeutics, Inc.	2	$118
Ferring Pharmaceuticals Inc.	1	$113
Olympus Latin America, Inc.	1	$108
Smith+Nephew	1	$102
Progenics Pharmaceuticals, Inc.	1	$92
Intuitive Surgical	1	$69
AbbVie	1	$56
Verity Pharmaceuticals Inc.	1	$54
Tolmar, Inc.	2	$46

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AquaBeam Robotic System$1,079
UroLift$584
OPDIVO$225
Erleada$213
AMS 700 CXR RTE KIT$139
GENERAL BPH$132
INTERSTIM$129
GENERAL - THERAPIES$125
Axonics r-SNM System$121
ADSTILADRIN$113
DARZALEX$113
TALVEY$113
RYBREVANT$113
4-K$108
UroLift System$103
ACTICOAT 4" X 4"$102
ALLEVYN Gentle Border Lite 10cm x 10cm$102
Iodosorb Ointment 40g USA$102
PICO$102
RENASYS TOUCH$102

How this compares

$5,542 in reported general payments places this provider in the 75th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024

$16,917

Medicare patients

Services billed

140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	48	$35,511
PremarinEstrogens, Conjugated	58	$25,802
Finasteride	916	$17,124
Tamsulosin Hcl	1,010	$15,976
Tolterodine Tartrate ErTolterodine Tartrate	72	$14,028
ElmironPentosan Polysulfate Sodium	11	$8,476
Alfuzosin Hcl ErAlfuzosin Hcl	116	$2,897
Ketorolac Tromethamine	57	$2,692
Bicalutamide	68	$2,035
Potassium Citrate ErPotassium Citrate	20	$2,012
NitrofurantoinNitrofurantoin Macrocrystal	71	$2,004
Oxybutynin Chloride ErOxybutynin Chloride	41	$1,567
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	556	$1,271
Levofloxacin	268	$1,221
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen	56	$791

Paid to pharmacies, not to this prescriber.

Other urology in Mayaguez

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →